Alaunos Therapeutics | ZIOP - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Baxter International USD 1.97B 240M 2025-12
Biogen USD 3.01B 854.3M 2025-12
Bioline Rx USD 7.91M 725K 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Curis USD 10.14M 10.14M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
J&J USD 19.71B 1.48B 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Merck USD 18.17B 10.16B 2025-09
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Novartis USD 9.56B 2.9B 2025-09
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pfizer USD 1.34B 295M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
TG Therapeutics USD 199.51M 21.2M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Verastem USD 137.71M 20.14M 2025-09
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06